These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 7524499

  • 1. Tetrafibricin has a high selectivity for GPIIb/IIIa: comparison of the effects of tetrafibricin and RGDS on GPIIb/IIIa and the vitronectin receptor.
    Satoh T, Kouns WC, Yamashita Y, Kamiyama T, Steiner B.
    Biochem Biophys Res Commun; 1994 Oct 14; 204(1):325-32. PubMed ID: 7524499
    [Abstract] [Full Text] [Related]

  • 2. Tetrafibricin: a nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis (I). Its GPIIb/IIIa blockage on solid phase binding assay.
    Satoh T, Yamashita Y, Kamiyama T, Watanabe J, Steiner B, Hadváry P, Arisawa M.
    Thromb Res; 1993 Dec 01; 72(5):389-400. PubMed ID: 8303682
    [Abstract] [Full Text] [Related]

  • 3. Tetrafibricin: a nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis. (II). Its antiplatelet activities.
    Satoh T, Yamashita Y, Kamiyama T, Arisawa M.
    Thromb Res; 1993 Dec 01; 72(5):401-12. PubMed ID: 8303683
    [Abstract] [Full Text] [Related]

  • 4. Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa.
    Satoh T, Kouns WC, Yamashita Y, Kamiyama T, Steiner B.
    Biochem J; 1994 Aug 01; 301 ( Pt 3)(Pt 3):785-91. PubMed ID: 7519850
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D, Lider O, Dardik R, Shenkman B, Alon R, Hershkoviz R, Kapustina G, Savion N, Martinowitz U, Greenspoon N.
    Thromb Haemost; 1993 Dec 20; 70(6):1030-6. PubMed ID: 8165596
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.
    Kieffer N, Fitzgerald LA, Wolf D, Cheresh DA, Phillips DR.
    J Cell Biol; 1991 Apr 20; 113(2):451-61. PubMed ID: 1707057
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. How vitronectin binds to activated glycoprotein IIb-IIIa complex and its function in platelet aggregation.
    Mohri H, Ohkubo T.
    Am J Clin Pathol; 1991 Nov 20; 96(5):605-9. PubMed ID: 1719797
    [Abstract] [Full Text] [Related]

  • 11. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets.
    Chen CS, Papayannopoulos IA, Timmons S, Chou SH, Thiagarajan P.
    Biochim Biophys Acta; 1991 Oct 31; 1075(3):237-47. PubMed ID: 1720019
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cation-dependent changes in the binding specificity of the platelet receptor GPIIb/IIIa.
    Kirchhofer D, Gailit J, Ruoslahti E, Grzesiak J, Pierschbacher MD.
    J Biol Chem; 1990 Oct 25; 265(30):18525-30. PubMed ID: 2211716
    [Abstract] [Full Text] [Related]

  • 14. Pentamidine is a specific, non-peptide, GPIIb/IIIa antagonist.
    Cox D, Aoki T, Seki J, Motoyama Y, Yoshida K.
    Thromb Haemost; 1996 Mar 25; 75(3):503-9. PubMed ID: 8701416
    [Abstract] [Full Text] [Related]

  • 15. Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking.
    Coller BS, Seligsohn U, West SM, Scudder LE, Norton KJ.
    Blood; 1991 Nov 15; 78(10):2603-10. PubMed ID: 1726706
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of von Willebrand factor binding to platelets by two recognition site peptides: the pentadecapeptide of the carboxy terminus of the fibrinogen gamma chain and the tetrapeptide arg-gly-asp-ser.
    Williams S, Gralnick H.
    Thromb Res; 1987 May 01; 46(3):457-71. PubMed ID: 3037722
    [Abstract] [Full Text] [Related]

  • 17. Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release.
    Mousa SA, Bozarth J, Forsythe M, Tsao P, Pease L, Reilly TM.
    Life Sci; 1994 May 01; 54(16):1155-62. PubMed ID: 8152339
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist.
    Foster MR, Hornby EJ, Brown S, Hann M, Kitchin J, Pike N, Ward P.
    Thromb Res; 1994 Aug 01; 75(3):269-84. PubMed ID: 7992238
    [Abstract] [Full Text] [Related]

  • 19. Platelet size distribution measurements as indicators of shear stress-induced platelet aggregation.
    Slack SM, Jennings LK, Turitto VT.
    Ann Biomed Eng; 1994 Aug 01; 22(6):653-9. PubMed ID: 7532923
    [Abstract] [Full Text] [Related]

  • 20. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex.
    Bennett JS, Shattil SJ, Power JW, Gartner TK.
    J Biol Chem; 1988 Sep 15; 263(26):12948-53. PubMed ID: 3417645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.